[1]
“FROM FIASP TO TRURAPI: CONVERSION IN INSULIN ASPART PRESCRIBING IN THE UNITED KINGDOM AND THE IMPACT OF DELIVERY-DEVICE PREFERENCES ”, Glob. j. public health med., vol. 8, no. 1 (Ongoing), pp. 200–215, Aug. 2026, doi: 10.37557/87533971.